Jayne Murray

2.1k total citations · 1 hit paper
23 papers, 817 citations indexed

About

Jayne Murray is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jayne Murray has authored 23 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 15 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jayne Murray's work include Neuroblastoma Research and Treatments (18 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jayne Murray is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jayne Murray collaborates with scholars based in Australia, United States and Italy. Jayne Murray's co-authors include Michelle Haber, Murray D. Norris, Maria Kavallaris, Glenn M. Marshall, Emanuele Valli, Federica Saletta, Aria Ahmed-Cox, Joseph A. Trapani, Florida Voli and Orazio Vittorio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Jayne Murray

21 papers receiving 809 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

2020 280 citations Florida Voli, Emanuele Valli et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jayne Murray Australia	12	415	239	229	176	146	23	817
Shuang Yan China	17	466 1.1×	215 0.9×	135 0.6×	72 0.4×	78 0.5×	50	801
Jigna Shah India	13	274 0.7×	387 1.6×	118 0.5×	144 0.8×	40 0.3×	43	868
Bernhard Erdlenbruch Germany	18	448 1.1×	175 0.7×	47 0.2×	126 0.7×	96 0.7×	32	965
Agshin F. Taghiyev United States	17	570 1.4×	133 0.6×	264 1.2×	157 0.9×	24 0.2×	25	946
Monish Ram Makena United States	13	562 1.4×	295 1.2×	196 0.9×	63 0.4×	124 0.8×	27	839
Daniela Annibali Belgium	18	601 1.4×	295 1.2×	257 1.1×	104 0.6×	35 0.2×	29	1.0k
Vincent M. Mann United Kingdom	12	280 0.7×	168 0.7×	120 0.5×	144 0.8×	57 0.4×	19	680
Xuejiao Liu China	20	595 1.4×	132 0.6×	213 0.9×	87 0.5×	28 0.2×	40	938
Vladislav O. Sviderskiy United States	8	1.5k 3.7×	244 1.0×	764 3.3×	672 3.8×	167 1.1×	14	2.1k
Md Kamrul Hasan United States	19	611 1.5×	316 1.3×	163 0.7×	48 0.3×	68 0.5×	43	1.1k

Countries citing papers authored by Jayne Murray

Since Specialization

Citations

This map shows the geographic impact of Jayne Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayne Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayne Murray more than expected).

Fields of papers citing papers by Jayne Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayne Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayne Murray. The network helps show where Jayne Murray may publish in the future.

Co-authorship network of co-authors of Jayne Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Jayne Murray. A scholar is included among the top collaborators of Jayne Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayne Murray. Jayne Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murray, Jayne, Lin Xiao, Klaartje Somers, et al.. (2023). Abstract B132: Addition of AMXT1501 (polyamine uptake inhibitor) plus DFMO (polyamine synthesis inhibitor) to standard-of-care chemotherapy/anti-GD2 antibody in the TH-MYCN mouse neuroblastoma model, enhances efficacy compared to addition of DFMO alone. Molecular Cancer Therapeutics. 22(12_Supplement). B132–B132.

Neznanov, Nickolay, Brandon M. Hall, Mairead Commane, et al.. (2022). Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences. 119(49). e2213146119–e2213146119. 10 indexed citations

Rouaen, Jourdin R.C., Daniele Mercatelli, Federica Saletta, et al.. (2022). Abstract 5214: Copper chelation overcomes the immunosuppressive tumor microenvironment in neuroblastoma. Cancer Research. 82(12_Supplement). 5214–5214.

Gifford, Andrew J., Jayne Murray, Jamie I. Fletcher, et al.. (2021). A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma. Current Protocols. 1(11). e310–e310. 3 indexed citations

Voli, Florida, Emanuele Valli, Luigi Lerra, et al.. (2020). Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research. 80(19). 4129–4144. 280 indexed citations breakdown →

Khan, Aaminah, Emanuele Valli, Hayley Lam, et al.. (2020). Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition. Oncogene. 39(17). 3555–3570. 31 indexed citations

Huynh, Tony, Jayne Murray, Claudia L. Flemming, et al.. (2019). CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth. Biochemical Pharmacology. 172. 113770–113770. 4 indexed citations

Dagg, Rebecca A., Hilda A. Pickett, Axel A. Neumann, et al.. (2017). Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres. Cell Reports. 19(12). 2544–2556. 72 indexed citations

Burns, Mark R., Kathy Fosnaugh, Michael G. Palfreyman, et al.. (2017). Abstract 2006: AMX-513 polyamine depletion therapy inhibits tumor growth and reverses immunosuppression in cancers including MYC-driven neuroblastoma and pancreatic cancer. Cancer Research. 77(13_Supplement). 2006–2006. 2 indexed citations

10.

Tran, Sieu L., Michelle F. Maritz, Bing Liu, et al.. (2016). MYC -Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin. Cancer Research. 76(12). 3604–3617. 36 indexed citations

11.

Evageliou, Nicholas F., Michelle Haber, Annette Vu, et al.. (2016). Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression. Clinical Cancer Research. 22(17). 4391–4404. 64 indexed citations

12.

Carter, Daniel R., Selina K. Sutton, Marina Pajic, et al.. (2016). Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis. Molecular Oncology. 10(6). 866–878. 20 indexed citations

13.

Pasquier, Eddy, Janine Street, Manon Carré, et al.. (2013). β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. British Journal of Cancer. 108(12). 2485–2494. 126 indexed citations

14.

Haber, Michelle, Jayne Murray, Hannah Webber, et al.. (2013). Abstract 2759: Anticancer compound curaxin CBL0137, that simultaneously suppresses NF-κB and activates p53, is highly effective in two independent mouse models of neuroblastoma.. Cancer Research. 73(8_Supplement). 2759–2759. 1 indexed citations

15.

Fletcher, Jamie I., Samuele Gherardi, Jayne Murray, et al.. (2011). N-Myc Regulates Expression of the Detoxifying Enzyme Glutathione Transferase GSTP1 , a Marker of Poor Outcome in Neuroblastoma. Cancer Research. 72(4). 845–853. 12 indexed citations

16.

Pajic, Marina, Jayne Murray, Glenn M. Marshall, et al.. (2011). ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript. Pharmacogenetics and Genomics. 21(5). 270–279. 18 indexed citations

17.

Burkhart, Catherine A., Fujiko Watt, Jayne Murray, et al.. (2009). Small-Molecule Multidrug Resistance–Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma. Cancer Research. 69(16). 6573–6580. 84 indexed citations

18.

Burkhart, Catherine A., Jayne Murray, Marina Pajic, et al.. (2008). Reversan, a novel inhibitor of MRP1, increases the therapeutic index of conventional chemotherapeutic agents. Cancer Research. 68. 3242–3242. 1 indexed citations

19.

Ashton, Lesley J., Jayne Murray, Michelle Haber, et al.. (2007). Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenetics and Genomics. 17(9). 709–717. 16 indexed citations

20.

Cheng, Andy, Ngan Ching Cheng, Jette Ford, et al.. (2007). Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. European Journal of Cancer. 43(9). 1467–1475. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact